1.Advances in reverse genetics-based vaccines of foot and mouth disease.
Bo YANG ; Fan YANG ; Song-Hao WANG ; Yan ZHANG ; Wei-Jun CAO ; Hong YIN ; Hai-Xue ZHENG
Chinese Journal of Virology 2014;30(2):213-220
Reverse-genetic engineering of foot and mouth disease virus (FMDV) can improve the productivity, antigen matching, antigen stability, immune response ability, and biological safety of vaccines, so vaccine candidates with anticipated biological characteristics can be promptly achieved. Negative influence in taming of virulent strains can also be decreased or avoided. Reverse genetics not only make up for deficiencies like limitation of viral nature, low success rate, and time and energy consuming, but also realize more active designing of vaccines. Therefore, reverse genetics is significant in improving integral quality and efficiency of vaccines. In this review, we use FMDV vaccines as an example to summarize improvement in biological characteristics of virulent strains and provide a reference for related researches.
Animals
;
Antibodies, Viral
;
immunology
;
Foot-and-Mouth Disease
;
immunology
;
prevention & control
;
virology
;
Foot-and-Mouth Disease Virus
;
genetics
;
immunology
;
Reverse Genetics
;
Viral Vaccines
;
genetics
;
immunology
2.High expression of the foot-and-mouth disease's structural protein P1 in Escherichia coli and analysis of its biology activity.
Xiao-Lan YU ; Shao-Bo XIAO ; Liu-Rong FANG ; Meng-Yu HU ; Lin YAN ; Xiao-Hui DONG ; Huan-Chun CHEN
Chinese Journal of Biotechnology 2005;21(1):163-166
Foot-and-mouth disease virus (FMDV) is the aetiological angent of a highly contagious viral disease. The complete gene encoding the structural protein of FMDV (P1) was subcloned into expression vector pGEX-KG, resulting in the fusion expression plasmid pKG-P1. After transformed into E. coli BL21(DE3) and induced by IPTG, the results of SDS-PAGE showed that the GST-P1 fusion protein was expressed in high level. The molecular weight of the fusion protein wa 110kD and the expressed products were soluble. Western-blotting was performed to confirm that the expressed fusion protein could specifically react with antiserum against FMDV. The fusion proteins were further purified by GST purification kit and an indirect ELISA (P1-ELISA) based on the purified proteins was developed. Comparison between P1-ELISA and the standard indirect haemagglutinin assay showed the two methods had 87 per cent agreement by detecting 864 serum samples, indicating the purified P1 protein was specific as the antigen of indirect P1-ELISA.
Capsid Proteins
;
biosynthesis
;
genetics
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Foot-and-Mouth Disease Virus
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
3.Construction of recombinant yellow fever virus 17D containing 2A fragment as a vaccine vector.
Pang XIAOWU ; Wen-Chuan FU ; Yin-Han GUO ; Li-Shu ZHANG ; Tian-Pei XIE ; Gu XINBIN
Chinese Journal of Biotechnology 2006;22(3):492-498
The Yellow Fever (YF) vaccine, an attenuated yellow fever 17D (YF-17D) live vaccine, is one of the most effective and safest vaccines in the world and is regarded as one of the best candidates for viral expression vector. We here first reported in China the construction and characterization of the recombinant expression vector of yellow fever 17D which contained the proteinase 2A fragment of foot-and-mouth disease virus (FMDV). Three cDNA fragments representing the full-length YF-17D genome, named 5'-end cDNA (A), 3'-end cDNA (B) and middle cDNA (C), were obtained by reverse transcription polymerase chain reaction (RT-PCR), together with the introduction of SP6 enhancer, necessary restriction sites and overlaps for homologous recombination in yeast. Fragment A and B were then introduced into pRS424 in turn by DNA recombination, followed by transfection of fragment C and the recombinant pRS424 containing A and B (pRS-A-B) into yeast. A recombinant vector containing full length cDNA of YF-17D (pRS-YF) was obtained by screening on medium lack of tryptophan and uracil. A recombinant YF-17D expression vector containing FMDV-2A gene fragment (pRS-YF-2A1) was then constructed by methods of DNA recombination and homologous recombination in yeast described above. In vitro transcription of the recombinant vector pRS-YF-2A1 was then carried out and introduced into BHK-21 cells by electroporation. Results of indirect immunofluorescence assay (IFA) and titer determination showed a stable infectious recombinant virus was gotten, whose features such as growth curve were similar to those of the parental YF-17D. The results suggest that the recombinant vector pRS-YF-2A1, by introduction of heterogenous genes via 2A region, is potential to be an effective live vaccine expression vector.
Animals
;
Cell Line
;
Cloning, Molecular
;
Cricetinae
;
Epitopes
;
immunology
;
Foot-and-Mouth Disease
;
prevention & control
;
Foot-and-Mouth Disease Virus
;
genetics
;
immunology
;
Genetic Engineering
;
Genetic Vectors
;
Recombination, Genetic
;
Saccharomyces cerevisiae
;
genetics
;
metabolism
;
Vaccines, Attenuated
;
Viral Vaccines
;
genetics
;
immunology
;
Yellow fever virus
;
genetics
;
immunology
4.Enhanced immune response of a novel T-cell immunogen in vaccine for foot-and-mouth disease.
Qing ZHAO ; Pu SUN ; Zaixin LIU ; Pinghua LI ; Huifang BAO ; Yimei CAO ; Xingwen BAI ; Yuanfang FU ; Zengjun LU ; Dong LI
Chinese Journal of Biotechnology 2011;27(9):1281-1291
We investigated the enhanced immune response of a recombinant T cell immunogen as an effective cellular immune adjuvant. The T cell immunogen named TI contained several T cell epitopes from the VP1, VP4, 3A and 3D proteins of foot-and-mouth disease virus (FMDV) and two pan-T helper (T(H)) cell sites to broaden the immunogenicity of the protein. Meanwhile, another fusion protein named OA-VP1 was expressed in bacteria, which contained two VP1 proteins of O and Asia1 type FMDV. Mice were vaccinated with commercially inactivated vaccine or OA-VP1 protein with or without the TI immunogen. The results show that mice inoculated with inactivated vaccine or OA-VP1 protein supplemented with TI immunogen produced significantly higher level of neutralizing antibodies (P < 0.01 or P < 0.05) than the mice only inoculated with inactivated vaccine or OA-VP1 protein by microneutralization assay. An obvious increase in T cell number by flow cytometric analysis and significantly higher concentration of IFN-gamma secreted in culture media of spleen lymphocytes were observed in groups supplemented with TI immunogen (P < 0.01). TI immunogen was an effective stimulator for humoral and cellular immunity and could help improve the immunogenicity of inactivated vaccine or protein subunit vaccine.
Adjuvants, Immunologic
;
pharmacology
;
Animals
;
Capsid Proteins
;
genetics
;
immunology
;
Epitopes, T-Lymphocyte
;
genetics
;
immunology
;
Foot-and-Mouth Disease
;
immunology
;
prevention & control
;
virology
;
Foot-and-Mouth Disease Virus
;
immunology
;
Immunization
;
Mice
;
Viral Vaccines
;
genetics
;
immunology
;
pharmacology
5.Construction and identification of a recombinant PRRSV expressing protective antigens of type O foot-and-mouth disease virus.
Wu TONG ; Yanzhao XU ; Yanjun ZHOU ; Yifeng JIANG ; Shanrui ZHANG ; Yaxin WANG ; Jianping ZHU ; Lingxue YU ; Jing SUN ; Huanchun CHEN ; Guangzhi TONG
Chinese Journal of Biotechnology 2012;28(12):1431-1440
Using mutation PCR, we cloned the target gene containing 421-480nt (141-160aa) and 598-639nt (200-213aa) of VP1 gene of foot and mouth disease virus (FMDV) into the deleted region (508-532aa) of Nsp2 gene of a highly pathogenic porcine reproductive and respiratory syndrome virus derived vaccine strain (HuN4-F112) that was used as vector. The recombinant cDNA was in vitro transcribed followed by transfection of BHK-21 cells for 36 h. Then, the supernatant of the cell culture was continuously seeded to monolayer of MARC-145 cells for recovery of the recombinant virus. CPE was obviously visible after a couple of passages in the seeded MARC-145, and the rescued virus (designated as rPRRSV-F112-O/VP1ep) was identified by Mlu I digestion, sequencing and immunofluorescence assay. Meanwhile, expression of inserted FMDV epitopes was also detected by indirect immunofluorescence assay with polyclonal antibodies against VP1 protein of FMDV. The analysis of biological characteristics shows that the titer of the rescued recombinant PRRSV (TCID50 = -log10(-6.75)/0.1 mL) was similar to its direct parental virus rHuN4-F112-delta508-532, but higher than rHuN4-F112.
Animals
;
Antigens, Viral
;
immunology
;
Base Sequence
;
Capsid Proteins
;
immunology
;
Cell Line
;
Cysteine Endopeptidases
;
genetics
;
Epitopes
;
genetics
;
Foot-and-Mouth Disease
;
immunology
;
prevention & control
;
Foot-and-Mouth Disease Virus
;
genetics
;
immunology
;
Molecular Sequence Data
;
Mutation
;
Porcine respiratory and reproductive syndrome virus
;
genetics
;
immunology
;
Recombination, Genetic
;
Swine
;
Transfection
;
Vaccines, Attenuated
;
genetics
;
immunology
;
Viral Envelope Proteins
;
genetics
;
immunology
;
Viral Vaccines
;
genetics
;
immunology
6.Molecular design and immunogenicity of a multiple-epitope foot-and-mouth disease virus antigen, adjuvants, and DNA vaccination.
Mingxiao MA ; Ningyi JIN ; Gefen YIN ; Huijun LU ; Chang LI ; Kuoshi JIN ; Zuyi QU
Chinese Journal of Biotechnology 2009;25(4):514-519
We designed and constructed a fuse expression gene OAAT and staphylococcal enterotoxin A (SEA) on the basis of the OAAT designed and constructed which consists of the structural protein VP1 genes from serotypes A and O FMDV, 5 major VP1 immunodominant epitopes from two genotypes of Asia1 serotype, and 3 Th2 epitopes originating from the non-structural protein, 3ABC gene and structural protein VP4 gene. The recombinant plasmids pEA was constructed using SEA as a genetic adjuvant. Expressions of target gene from the pEA in Hela cell were verified by IFA and Western blotting. The experiment of BALB/c mice immunized with the DNA vaccines showed that pA and pEA could induce simultaneously specific antibodies against serotypes A, Asia1, and O FMDV, and the highest antibody titres were found in the pEA and inactivated vaccine groups compared to pA vaccinating mice. Compared with the control, the levels of IL-2, IFN-gamma, IL-4, and IL-10 expression by splenic lymphocytes from mice immunized with pA and pEA were significantly increased. In addition, we found that the levels of IL-2, IFN-gamma and IL-4 from the mice immunized with pEA was higher than mice immunized with pA did. The results of viral challenge in guinea pigs showed the pA, pEA and inactivated vaccine provided full protection in 2/4, 2/4, 3/4, 3/4 and 4/4, 4/4 guinea pigs from challenge with FMDV O/NY00 and Asial/YNBS/58, respectively. The results demonstrated fuse protein OAAT and SEA may be potential immunoge against FMDV, furthermore, SEA may be an effective genetic adjuvant for DNA vaccine.
Adjuvants, Immunologic
;
genetics
;
Animals
;
Antigens, Viral
;
immunology
;
Capsid Proteins
;
genetics
;
immunology
;
Enterotoxins
;
genetics
;
immunology
;
Epitopes
;
immunology
;
Foot-and-Mouth Disease
;
immunology
;
prevention & control
;
Foot-and-Mouth Disease Virus
;
immunology
;
Guinea Pigs
;
HeLa Cells
;
Humans
;
Mice
;
Mice, Inbred BALB C
;
Peptide Fragments
;
genetics
;
immunology
;
Vaccines, DNA
;
immunology
;
Viral Structural Proteins
;
genetics
;
immunology
;
Viral Vaccines
;
immunology
7.Enhanced immune response with foot and mouth disease virus VP1 and interleukin-1 fusion genes.
Jong Hyeon PARK ; Sun Jin KIM ; Jae Ku OEM ; Kwang Nyeong LEE ; Yong Joo KIM ; Soo Jeong KYE ; Jee Yong PARK ; Yi Seok JOO
Journal of Veterinary Science 2006;7(3):257-262
The capsid of the foot and mouth disease (FMD) virus carries the epitopes that are critical for inducing the immune response. In an attempt to enhance the specific immune response, plasmid DNA was constructed to express VP1/interleukin-1alpha (IL-1alpha) and precursor capsid (P1) in combination with 2A (P1-2A)/IL-1alpha under the control of the human cytomegalovirus (HCMV) immediateearly promoter and intron. After DNA transfection into MA104 (monkey kidney) cells, Western blotting and an immunofluorescence assay were used to confirm the expression of VP1 or P1-2A and IL-1alpha. Mice were inoculated with the encoding plasmids via the intradermal route, and the IgG1 and IgG2a levels were used to determine the immune responses. These results show that although the immunized groups did not carry a high level of neutralizing antibodies, the plasmids encoding the VP1/ IL-1alpha, and P1-2A /IL-1alpha fused genes were effective in inducing an enhanced immune response.
Animals
;
Antibodies, Viral/blood
;
Capsid Proteins/biosynthesis/genetics/*immunology
;
Cell Line
;
DNA, Viral/genetics
;
Enzyme-Linked Immunosorbent Assay
;
Foot-and-Mouth Disease/*immunology/prevention&control
;
Foot-and-Mouth Disease Virus/genetics/*immunology
;
Haplorhini
;
Immunization
;
Interleukin-1/biosynthesis/genetics/*immunology
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Plasmids/genetics
;
Polymerase Chain Reaction
;
Recombinant Fusion Proteins/biosynthesis/genetics/immunology
;
Specific Pathogen-Free Organisms
;
Transfection
;
Vaccines, DNA/genetics/*immunology
8.Prokaryotic expression and bioreactivity analysis of a major epitope region of 2C with 3AB within non-structural protein of foot-and-mouth disease virus.
Xiaoli ZHANG ; Meina TIAN ; Zengjun LU ; Yuanfang FU ; Xiaojun MA ; Zaixin LIU ; Qingge XIE
Chinese Journal of Biotechnology 2009;25(1):10-15
In recent years, the potential value of nonstructural protein (NSP) 2C was well documented for distinguishing foot-and-mouth disease virus (FMDV) in infected animals and vaccinated animals. In order to develop a more sensitive approach to detect natural infected FMDV while there is no interact with vaccinated FMDV, we incorporated a major epitope region of 2C with whole 3AB coding region within NSP and expressed in Escherichia coli. We got a 47.6 kD fusion protein named 2C'3AB. The product showed a specific reactivity with FMDV from serum of infected animal by using Western blotting analysis. This suggests that this protein could be applied to distinguish infected FMDV and vaccinated FMDV. We further compared 2C'3AB protein with 3ABC fusion protein, another available protein used for detecting infected FMDV, using indirect ELISA assay. The results showed that 2C'3AB-ELISA had higher sensitivity than that of 3ABC-ELISA for distinguishing infected FMDV and vaccinated FMDV of sera from epidemic region. Therefore, this recombinant protein 2C'3AB is a good candidate protein to develop more sensitive method to differentiate infected FMDV and vaccinated FMDV from vaccinated animals. This finding will increase our capability to check the infectious virus carrier and finally improve FMDV infection control.
Animals
;
Antibody Specificity
;
Carrier Proteins
;
genetics
;
immunology
;
metabolism
;
Epitopes
;
immunology
;
Escherichia coli
;
genetics
;
metabolism
;
Foot-and-Mouth Disease Virus
;
genetics
;
Recombinant Fusion Proteins
;
genetics
;
immunology
;
metabolism
;
Viral Nonstructural Proteins
;
genetics
;
immunology
;
metabolism
9.Construction and eukaryotic expression of recombinant plasmid encoding fusion protein of goat complement C3d and foot-and-mouth disease virus VP1.
Jieyu LING ; Zhao LIU ; Tiezhu TONG ; Huiying FAN ; Dekun ZHANG ; Huanchun CHEN ; Aizhen GUO
Chinese Journal of Biotechnology 2008;24(2):209-213
We constructed a recombinant plasmid encoding VP1 gene of O type foot-and-mouth disease virus fused to a molecular adjuvant, goat complement C3d gene. The goat C3d gene was cloned and three copies were tandem-linked with the linker (G4S)2 sequence. VP1 gene of O type foot-and-mouth disease virus was linked to three tandem repeats of C3d through the linker sequence and cloned into pUC19 to obtain the recombinant plasmid pUC19-VP1-C3d3. The VP1-C3d3 fusion gene was then subcloned into the eukaryotic vector pcDNA3.1(+) that had been modified to contain the tissue plasminogen activator (tPA) leader sequence to obtain pcDNA3.1-tPA-VP1-C3d3. HeLa cells were transfected with pcDNA3.1-tPA-VP1-C3d3 by Lipofectamine 2000. Indirect immunofluorescent assay and Western blot assay showed that VP1-C3d3 fusion gene was successfully expressed in HeLa cells. The fusion protein with the expected size 133 kD could be secreted outside the cells. This study laid a good foundation to further research on the novel vaccine against foot-and-mouth disease virus by using goat C3d as a molecular adjuvant to enhance the immunogenicity of VP1.
Animals
;
Capsid Proteins
;
biosynthesis
;
genetics
;
Cloning, Molecular
;
Complement C3d
;
biosynthesis
;
genetics
;
immunology
;
Female
;
Foot-and-Mouth Disease Virus
;
genetics
;
Goats
;
HeLa Cells
;
Humans
;
Immunologic Factors
;
biosynthesis
;
genetics
;
immunology
;
Plasmids
;
genetics
;
Recombinant Fusion Proteins
;
biosynthesis
;
genetics
;
immunology
;
Transfection
10.Expression and utilization of 3AB nonstructural protein of foot-and-mouth disease virus in Escherichia coli.
Junjun SHAO ; Huiyun CHANG ; Tong LIN ; Guozheng CONG ; Junzheng DU ; Shandian GAO
Chinese Journal of Biotechnology 2011;27(2):180-184
To develop a sensitive and specific ELISA for detection of antibodies to the nonstructural protein of FMDV. We cloned and expressed FMDV nonstructural protein 3AB in Escherichia coli expression system. The recombinant protein 3AB was purified with Ni-NTA HisBind Resins and characterized by Western blotting. An indirect ELISA based on purified protein 3AB as a coating antigen was established. The specificity and sensitivity of this assay were evaluated by comparison with a commercial 3ABC-ELISA kit in detecion of serum samples. The results showed that the recombinant protein 3AB was expressed as a formation of inclusion bodies in Escherichia coli. The purified protein could specificially react with FMDV infection antibodies in Western blotting assay, but no reaction with the immune antibodies induced with vaccine. Two assays were no significant differences in specificity and sensitivity for detection of field samples (P>0.05). Therefore, we speculated that the recombinant protein 3AB is a promising molecular marker, which may effectively differentiate FMD-infected from vaccinated animals in a herd.
Animals
;
Antibodies, Viral
;
analysis
;
Antigens, Viral
;
biosynthesis
;
genetics
;
immunology
;
Cattle
;
Cattle Diseases
;
diagnosis
;
immunology
;
Enzyme-Linked Immunosorbent Assay
;
Escherichia coli
;
genetics
;
metabolism
;
Foot-and-Mouth Disease
;
diagnosis
;
immunology
;
Foot-and-Mouth Disease Virus
;
chemistry
;
genetics
;
isolation & purification
;
Genetic Vectors
;
genetics
;
Recombinant Proteins
;
biosynthesis
;
genetics
;
immunology
;
Viral Nonstructural Proteins
;
biosynthesis
;
genetics
;
immunology